Based on the VanEck Biotech ETF stock forecast from 0 analysts, the average analyst target price for VanEck Biotech ETF is not available over the next 12 months. VanEck Biotech ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of VanEck Biotech ETF is Very Bullish, which is based on 5 positive signals and 0 negative signals. At the last closing, VanEck Biotech ETF’s stock price was USD 170.41. VanEck Biotech ETF’s stock price has changed by -1.14% over the past week, -2.83% over the past month and -62.57% over the last year.
No recent analyst target price found for VanEck Biotech ETF
No recent average analyst rating found for VanEck Biotech ETF
Company Overview VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. Read Less
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-c...Read More
Frequently Asked Questions About VanEck Biotech ETF (BBH) Stock
Stock Target Advisor's fundamental analysis for VanEck Biotech ETF's stock is Very Bullish.
BBH stock's dividend yield is 0.40%.
Our analysis grades BBH stock's dividend yield at D+. This means that BBH stock's dividend yield is above 67% of the stocks in the Health sector in the NSD exchange.
Based on this BBH may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BBH's stock to indicate what its average analyst target is.
BBH stock's Price/Earning ratio is 8.01.
Our analysis grades BBH stock's Price / Earning ratio at A+. This means that BBH stock's Price/Earning ratio is above 0% of the stocks in the Health sector in the NSD exchange.
Based on this BBH may be undervalued for its sector.
The last closing price of BBH's stock was USD 170.41.
The most recent market capitalization for BBH is USD 0.43B.
Unfortunately we do not have enough analyst data on BBH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains VanEck Biotech ETF's stock.
As per our most recent records VanEck Biotech ETF has 0 Employees.
VanEck Biotech ETF's registered address is Seestrasse 16, Kusnacht, Switzerland, 8700.
You can get more information about it from VanEck Biotech ETF's website at http://www.vaneck.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About VanEck Biotech ETF (BBH) Stock
Stock Target Advisor's fundamental analysis for VanEck Biotech ETF's stock is Very Bullish.
BBH stock's dividend yield is 0.40%.
Our analysis grades BBH stock's dividend yield at D+. This means that BBH stock's dividend yield is above 67% of the stocks in the Health sector in the NSD exchange.
Based on this BBH may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BBH's stock to indicate what its average analyst target is.
BBH stock's Price/Earning ratio is 8.01.
Our analysis grades BBH stock's Price / Earning ratio at A+. This means that BBH stock's Price/Earning ratio is above 0% of the stocks in the Health sector in the NSD exchange.
Based on this BBH may be undervalued for its sector.
The last closing price of BBH's stock was USD 170.41.
The most recent market capitalization for BBH is USD 0.43B.
Unfortunately we do not have enough analyst data on BBH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains VanEck Biotech ETF's stock.
As per our most recent records VanEck Biotech ETF has 0 Employees.
VanEck Biotech ETF's registered address is Seestrasse 16, Kusnacht, Switzerland, 8700.
You can get more information about it from VanEck Biotech ETF's website at http://www.vaneck.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BBH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
